Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Floradapt Mature Immune Defense + multivitamin is a probiotic dietary supplement developed by Kaneka (Kaneka Americas Holding, Inc.). The formulation consists of two specific strains of *Lactiplantibacillus plantarum* (KABP-031 and KABP-032) with a combined strength exceeding 1 x 10^9 CFU, administered in conjunction with a multivitamin complex. The product is specifically designed to support immune health, digestive function, and nutrient uptake in healthy elderly populations (adults aged 65 and older). Clinical investigations have focused on its effects on gastrointestinal health, bowel function, and the absorption of essential nutrients such as Vitamin B12, Vitamin C, and folate, which are critical for maintaining immune resilience in the aging gut microbiome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Floradapt Mature Immune Defense + multivitamin.